[go: up one dir, main page]

HK1028615A1 - Isolated nona-and decapeptides which bind to hla molecules, and the use thereof - Google Patents

Isolated nona-and decapeptides which bind to hla molecules, and the use thereof

Info

Publication number
HK1028615A1
HK1028615A1 HK00108003A HK00108003A HK1028615A1 HK 1028615 A1 HK1028615 A1 HK 1028615A1 HK 00108003 A HK00108003 A HK 00108003A HK 00108003 A HK00108003 A HK 00108003A HK 1028615 A1 HK1028615 A1 HK 1028615A1
Authority
HK
Hong Kong
Prior art keywords
decapeptides
bind
hla molecules
nona
isolated
Prior art date
Application number
HK00108003A
Other languages
English (en)
Inventor
Danila Valmori
Jean-Charles Cerottini
Pedro Romero
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/880,963 external-priority patent/US6025470A/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of HK1028615A1 publication Critical patent/HK1028615A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00108003A 1997-06-23 2000-12-13 Isolated nona-and decapeptides which bind to hla molecules, and the use thereof HK1028615A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/880,963 US6025470A (en) 1997-06-23 1997-06-23 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
US09/061,388 US6277956B1 (en) 1997-06-23 1998-04-16 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
PCT/US1998/012879 WO1998058951A1 (en) 1997-06-23 1998-06-18 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof

Publications (1)

Publication Number Publication Date
HK1028615A1 true HK1028615A1 (en) 2001-02-23

Family

ID=26741014

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108003A HK1028615A1 (en) 1997-06-23 2000-12-13 Isolated nona-and decapeptides which bind to hla molecules, and the use thereof

Country Status (9)

Country Link
US (3) US6326200B1 (xx)
EP (1) EP1012173B1 (xx)
CN (1) CN1313481C (xx)
AT (1) ATE377022T1 (xx)
AU (1) AU732468B2 (xx)
CA (1) CA2295321C (xx)
HK (1) HK1028615A1 (xx)
NZ (1) NZ501752A (xx)
WO (1) WO1998058951A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU732468B2 (en) * 1997-06-23 2001-04-26 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
AU6801800A (en) * 1999-08-30 2001-03-26 Ludwig Institute For Cancer Research Isolated nona and decapeptides which bind to hla molecules, and the use thereof
WO2001030847A1 (en) 1999-10-22 2001-05-03 Aventis Pasteur Limited Modified gp100 and uses thereof
EP1266221A1 (en) * 2000-01-20 2002-12-18 Ludwig Institute For Cancer Research Mage antigenic peptides which bind hla-b35 and hla-b44
FR2806727A1 (fr) * 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
CA2492823A1 (en) * 2001-09-14 2003-03-27 Martin F. Bachmann In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
JP4516748B2 (ja) * 2001-09-14 2010-08-04 サイトス バイオテクノロジー アーゲー ウィルス様粒子中への免疫賦活物質のパッケージ化：調製法および使用法
PL375306A1 (en) * 2002-06-20 2005-11-28 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
WO2004029071A2 (en) 2002-09-27 2004-04-08 Ludwig Institute For Cancer Research Mage-c2 antigenic peptides and uses thereof
US20060210588A1 (en) * 2003-03-26 2006-09-21 Cytos Biotechnology Ag Hiv-peptide-carrier-conjugates
WO2004084940A1 (en) * 2003-03-26 2004-10-07 Cytos Biotechnology Ag Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
AU2006277295B2 (en) * 2005-08-09 2011-08-11 Oncotherapy Science, Inc. Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
US20070184068A1 (en) * 2005-12-14 2007-08-09 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
ES2738986T3 (es) 2006-06-12 2020-01-28 Kuros Biosciences Ag Procesos para empaquetar oligonucleótidos en partículas de tipo viral de bacteriófagos de ARN
WO2018094570A1 (zh) * 2016-11-22 2018-05-31 深圳华大基因研究院 多肽及其应用
CN109923121B (zh) * 2016-11-22 2022-12-23 武汉华大吉诺因生物科技有限公司 多肽及其应用
WO2018098715A1 (zh) * 2016-11-30 2018-06-07 深圳华大基因研究院 多肽及其应用
WO2024216241A2 (en) * 2023-04-14 2024-10-17 The Johns Hopkins University Heteroclitic neoepitope vaccines

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US5487974A (en) * 1992-12-22 1996-01-30 Ludwig Institute For Cancer-Research Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells
US5554506A (en) 1994-03-24 1996-09-10 Ludwig Institute For Cancer Research Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US5554724A (en) 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
US5851523A (en) * 1994-03-24 1998-12-22 Ludwig Institute For Cancer Research. Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
CA2188432C (en) * 1994-04-22 2011-02-01 Yutaka Kawakami Melanoma antigens
US5874560A (en) * 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
CA2252675A1 (en) * 1996-04-26 1997-11-06 Rijksuniversiteit Te Leiden Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
AU732468B2 (en) * 1997-06-23 2001-04-26 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
US6025470A (en) * 1997-06-23 2000-02-15 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

Also Published As

Publication number Publication date
EP1012173A4 (en) 2000-07-05
EP1012173A1 (en) 2000-06-28
NZ501752A (en) 2000-12-22
US6326200B1 (en) 2001-12-04
EP1012173B1 (en) 2007-10-31
CA2295321C (en) 2008-01-29
AU7982798A (en) 1999-01-04
CN1261374A (zh) 2000-07-26
US7713714B2 (en) 2010-05-11
US7344879B2 (en) 2008-03-18
US20040152193A1 (en) 2004-08-05
AU732468B2 (en) 2001-04-26
ATE377022T1 (de) 2007-11-15
US20030082804A1 (en) 2003-05-01
CA2295321A1 (en) 1998-12-30
WO1998058951A1 (en) 1998-12-30
CN1313481C (zh) 2007-05-02

Similar Documents

Publication Publication Date Title
HK1028615A1 (en) Isolated nona-and decapeptides which bind to hla molecules, and the use thereof
ZA983089B (en) Sustained-release alginate gels
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ZA961481B (en) Isolated nonapeptides presented by hla molecules and uses thereof
AU3036597A (en) Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
CA96914S (en) Electric par lamp
CA95794S (en) Paving stone
ZA985457B (en) Isolated nona- and decapeptides which bind to HLA molecules and the use thereof
BG100248A (en) Squalene synthetase inhibitors
IL139604A0 (en) Novel peptides
UA32604C2 (uk) Парорегулювальний клапан для парових турбін
AU6801800A (en) Isolated nona and decapeptides which bind to hla molecules, and the use thereof
ZA986939B (en) An apparatus for the manufacture of individual holograms to make documents secure.
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use
IL135516A0 (en) Process for n-desmethylating erythromycins and derivatives thereof
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
EP1051507A4 (en) ANTIGEN-SPECIFIC CELLS, METHODS OF MAKING AND USES THEREOF
AU128987S (en) A clip for a bin
PT1017377E (pt) Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina
UA28187A (uk) Лопатевий неповноповоротний гідродвигун
ZA9710343B (en) Utilization of an egg-based preparation as an antidepressant.
JO1912B1 (en) The Universe Scientific Hour

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160618